JSI has been supporting Ministries of Health in eight countries as they plan for and introduce this life-saving vaccine, and in doing so has learned a lot about how to reach adolescent girls.
JSI and MCSP worked with stakeholders at multiple levels of the health system, assisting the local government to improve planning for vaccine delivery, and developing multiple strategies to try to raise and maintain Tabora’s MCV 2 coverage rate.
Despite the demonstrated benefits of peer learning in the global south, rarely had the approach been applied in Africa. In October 2018, JSI led an initiative to foster technical leadership through inter-country peer-to-peer exchange in sub-Saharan Africa.
As 2019 begins, Lora Shimp, co-director of JSI’s Immunization Center, provides her thoughts on how the global immunization community is envisioning the exciting decade ahead.
Recently, JSI, in partnership with Nexleaf Analytics, installed ColdTrace 5, a remote temperature monitoring (RTM) device, in 120 vaccine storage sites across Tanzania. RTM solutions monitor the temperature of vaccine cold chain equipment in real time, send SMS alerts to health workers when temperature excursions occur, and provide valuable data and analytics to improve the overall cold chain. Seeing the performance of the fridge in real time allows for better management of the cold chain equipment and vaccines.
In this episode, you will hear from JSI Immunization Expert, Robert Steinglass. He talks to JSI Program Manager, Adriana Alminana about the importance of vaccination for improved public health and the growing need to increase focus on strengthening routine immunization systems for sustainability and equity.
The Internet of Things is already taking off in many different areas: in healthcare with drones delivering medical supplies to remote areas; energy management systems for buildings that will automatically adjust the window blinds based on the temperature; or traffic conditions that update your Google maps and give you real-time driving directions. In Tanzania, we are using it to manage vaccines so that children can receive safe vaccinations and lead healthy lives.
Last year, it was estimated that 1,804 of the 3,194 women in Madagascar who suffered from cervical cancer died. The HPV vaccine is not only a cost-effective method to prevent the economic burden of cervical cancers; it also protects against other types of cancers and symptoms of HPV, such as pelvic inflammatory disease.
Rapid urbanization presents an urgent challenge for the world’s low- and middle-income countries. More than half of world’s population (3.9 billion) now lives in a city; by 2050, this number will skyrocket to 6.3 billion, with 90 percent of growth occurring in low- and middle-income countries. The first step to meeting the immunization needs of the urban poor is revealing the obstacles to vaccine access.
For Nigeria to improve its health outcomes, particularly to end vaccine-preventable child deaths, the highest level of commitment and accountability from Nigerian leaders is imperative.